As Novo Nordisk cuts 9,000 people from its organization in a restructuring effort, BioSpace looks back on the Danish pharma company’s rise.
Novo’s Headcount Rose 81% in Five Years as Revenue Climbed Read More »
Hospital finances have been generally strong this year, but the future is precarious as expenses — including non-labor costs — rise, according to an analysis by Kaufman Hall.
Hospital financial performance holds steady, but headwinds loom: report Read More »
These 27 markets, comprising countries across Asia, Europe and South America, together contributed some 12% of Lundbeck’s earnings in 2024.
Lundbeck Offloads Assets to Three Partners as it Exits 27 Markets, Leaving 602 Jobless Read More »
Former CDC director Susan Monarez and former chief medical officer Debra Houry will appear in front of the Senate HELP Committee on Sept. 17.
Ousted CDC Director Monarez to Testify In Front of Senate After RFK Jr. Clash Read More »
Cullinan Therapeutics and Taiho Oncology’s zipalertinib elicited promising response rates in two mid-stage studies of non-small cell lung cancer patients with typical and uncommon EGFR mutations.
Cullinan, Taiho’s NSCLC Hopeful Shows ‘Strong Activity,’ Clearing Road to FDA Read More »
Jefferies analysts expect a regulatory filing for rocatinlimab later this year, with a product launch in 2026.
Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful Read More »
Novo Nordisk also lowered its full-year profit growth guidance in connection with the restructuring effort. The pharma now anticipates operating profit to grow from 4% to 10%, down from its prior projection of 10% to 16%.
Novo Axes 9,000 Employees Worldwide as New CEO Makes Good on Cost Reallocation Promise Read More »
La quimioterapia busca acabar con las células tumorales mediante fármacos, y es desde hace décadas un tratamiento habitual contra el cáncer. Sin embargo, no siempre da buen resultado. Ahora, gracias a una investigación en la que se han descubierto biomarca …
This week’s release of the Make America Health Again report TKTK; Health Secretary Robert F. Kennedy Jr.’s faceoff with senators last week amounted to political theater; the FDA promises complete response letters in real time and shares details on a new rare disease framework; and Summit disappoints at the World Conference on Lung Cancer in
Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More Read More »
Unos científicos han creado una molécula, inspirada en la fotosíntesis vegetal, que bajo la influencia de la luz, almacena dos cargas eléctricas positivas y dos negativas al mismo tiempo. El objetivo final es convertir la luz solar en combustibles neutros en carbono. &nb …
Paso importante hacia una fotosíntesis artificial sostenible Read More »
